Latest Insider Transactions at Satsuma Pharmaceuticals, Inc. (STSA)
This section provides a real-time view of insider transactions for Satsuma Pharmaceuticals, Inc. (STSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Satsuma Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Satsuma Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 08
2023
|
Ra Capital Management, L.P. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,914,252
-100.0%
|
-
|
Jun 08
2023
|
Shin Nippon Biomedical Laboratories, Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,423,732
+50.0%
|
$0
$0.91 P/Share
|
Jun 06
2023
|
Rajeev M. Shah Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,914,252
-100.0%
|
$0
$0.91 P/Share
|
Jun 06
2023
|
Thomas P. O'Neil Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,877
-100.0%
|
$0
$0.91 P/Share
|
Jun 06
2023
|
Ken Takanashi Director |
BUY
Open market or private purchase
|
Indirect |
22,053,581
+47.02%
|
$0
$0.91 P/Share
|
Jun 06
2023
|
John A Kollins President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
305,911
-100.0%
|
$0
$0.91 P/Share
|
Jun 06
2023
|
Shin Nippon Biomedical Laboratories, Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,053,581
+50.0%
|
$0
$0.91 P/Share
|
Nov 21
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
150,000
+50.0%
|
$0
$0.71 P/Share
|
Nov 15
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
831,694
+6.21%
|
$0
$0.63 P/Share
|
Nov 14
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,608,306
+50.0%
|
$0
$0.69 P/Share
|
Nov 14
2022
|
Commodore Capital LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,250,000
-87.57%
|
$0
$0.71 P/Share
|
Nov 24
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,922
+0.08%
|
$14,610
$5.42 P/Share
|
Nov 22
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,979
+0.27%
|
$49,895
$5.49 P/Share
|
Nov 19
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,225
+0.09%
|
$16,125
$5.44 P/Share
|
Nov 11
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,941
+0.21%
|
$47,646
$6.05 P/Share
|
Nov 10
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,622
+0.26%
|
$48,110
$5.85 P/Share
|
Nov 08
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
560
+0.02%
|
$2,800
$5.99 P/Share
|
Nov 05
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,800
+0.21%
|
$39,000
$5.95 P/Share
|
Nov 04
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,400
+0.04%
|
$7,000
$5.88 P/Share
|
Nov 02
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,880
+0.24%
|
$44,400
$5.64 P/Share
|
Oct 29
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
44,651
+1.21%
|
$223,255
$5.71 P/Share
|
Oct 28
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,082
+0.42%
|
$75,410
$5.55 P/Share
|
Oct 27
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
39,581
+1.09%
|
$197,905
$5.45 P/Share
|
Oct 22
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
27,629
+0.77%
|
$138,145
$5.51 P/Share
|
Oct 21
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,816
+0.92%
|
$164,080
$5.4 P/Share
|
Oct 20
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,663
+1.15%
|
$203,315
$5.44 P/Share
|
Oct 19
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
87,580
+2.47%
|
$437,900
$5.07 P/Share
|
Oct 18
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,194
+1.06%
|
$144,776
$4.87 P/Share
|
Oct 15
2021
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
126,000
+3.64%
|
$504,000
$4.83 P/Share
|
Apr 01
2021
|
Ra Capital Management, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
758,398
+26.74%
|
$3,791,990
$5.91 P/Share
|
Feb 26
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,232,394
+19.29%
|
$6,161,970
$5.68 P/Share
|
Sep 17
2019
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,333,333
+22.17%
|
$19,999,995
$15.0 P/Share
|
Sep 17
2019
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
3,348,525
+39.29%
|
-
|